Merck & Co., Inc. (MRK)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
81.18-1.28 (-1.55%)
At close: 4:00PM EST
81.10 -0.06 (-0.07%)
Before hours: 7:41AM EST
| Previous close | 82.46 |
| Open | 81.81 |
| Bid | 81.01 x 1400 |
| Ask | 81.16 x 900 |
| Day's range | 80.96 - 82.30 |
| 52-week range | 65.25 - 89.20 |
| Volume | 8,625,424 |
| Avg. volume | 8,940,487 |
| Market cap | 205.388B |
| Beta (5Y monthly) | 0.44 |
| PE ratio (TTM) | 17.93 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.60 (3.20%) |
| Ex-dividend date | 14 Dec 2020 |
| 1y target est | N/A |
- Zacks
Merck's (MRK) Heart Failure Drug Vericiguat Gets FDA Nod
Merck (MRK)/Bayer's (BAYRY) vericiguat gets FDA approval for symptomatic chronic heart failure and reduced ejection fraction
- Zacks
Cocrystal Pharma (COCP) Completes Research Obligations With Merck
Cocrystal (COCP) completes all research obligations under the Merck exclusive worldwide license and collaboration agreement.
- Zacks
Why Merck (MRK) is Poised to Beat Earnings Estimates Again
Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
© 2021 Verizon Media. All rights reserved.
